Metraipolis › archive › dc_940ace0fdee5

Accelerating Neoantigen Discovery: A High-Throughput Approach to Immunogenic Target Identification — Europe PMC PMID:40872950

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40872950
DOI
10.3390/vaccines13080865
License (as archived)
solo-consultazione
Archived
2026-11-10T14:19:51.333Z
SHA-256 of the archived text
94b406cf2904c8b7543d913baba54243c9ab89ff116f0d74ba6817c12c7e0b4d
Stable URL of this page
https://metraipolis.com/documento/dc_940ace0fdee5

How to cite

Accelerating Neoantigen Discovery: A High-Throughput Approach to Immunogenic Target Identification — Europe PMC PMID:40872950 — Europe PMC (en), https://europepmc.org/article/MED/40872950 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_940ace0fdee5 (Metraipolis archive dc_940ace0fdee5, sha256 94b406cf2904c8b7543d913baba54243c9ab89ff116f0d74ba6817c12c7e0b4d)
BibTeX
@misc{dc940ace0fdee5,
  title = {Accelerating Neoantigen Discovery: A High-Throughput Approach to Immunogenic Target Identification — Europe PMC PMID:40872950},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40872950},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_940ace0fdee5; sha256 94b406cf2904c8b7543d913baba54243c9ab89ff116f0d74ba6817c12c7e0b4d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40872950. Agents can read the archived copy with the MCP tool read_document.